FDA ephedrine alkaloids adverse reaction data requested by House subcommittee.
This article was originally published in The Tan Sheet
Executive Summary
EPHEDRINE ADVERSE EVENT DATA REQUESTED BY HOUSE SUBCOMMITTEE in a Dec. 10 letter from Government Reform & Oversight/Human Resources Subcommittee Chairman Christopher Shays (R-Conn.) to FDA Lead Deputy Commissioner Michael Friedman, MD. "The Subcommittee on Human Resources is investigating the circumstances prompting [FDA's] proposed rule on maximum ephedrine alkaloid dosages," Shays states. FDA published its proposed rule on ephedrine alkaloids in the June 4 Federal Register ("The Tan Sheet" June 9, pp. 20-23).
You may also be interested in...
Burton, Durbin Chairmanships End; DSHEA Reform May Still Garner Interest
Rep. Dan Burton (R-Ind.) will step down as chairman of the House Government Reform Committee after his six-year term expires in December
Burton, Durbin Chairmanships End; DSHEA Reform May Still Garner Interest
Rep. Dan Burton (R-Ind.) will step down as chairman of the House Government Reform Committee after his six-year term expires in December
Burton, Durbin Chairmanships End; DSHEA Reform May Still Garner Interest
Rep. Dan Burton (R-Ind.) will step down as chairman of the House Government Reform Committee after his six-year term expires in December